Circulating microRNA associated with TNF-α signaling pathway in patients with plaque psoriasis

Journal of Dermatological Science

Volumn 61, Issue 3, 2011, Pages 209-211

  Oyama, Rie ^a   Jinnin, Masatoshi ^a   Kakimoto, Asako ^a   Kanemaru, Hisashi ^a   Ichihara, Asako ^a   Fujisawa, Akihiko ^a   Honda, Noritoshi ^a   Masuguchi, Shinich ^a   Fukushima, Satoshi ^a   Maruo, Keishi ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 130A; MICRORNA 19A; MICRORNA 29A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79951580189     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.12.008     Document Type: Letter

References (10)

1. Caldarola G., De Simone C., Carbone A., Tulli A., Amerio P., Feliciani C. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept. Int J Immunopathol Pharmacol 2009, 22(4):961-966.
2. Kristensen M., Chu C.Q., Eedy D.J., Feldmann M., Brennan F.M., Breathnach S.M. Localization of tumour necrosis factor-α (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 1993, 94(2):354-362.
3. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20.
4. Kroh E.M., Parkin R.K., Mitchell P.S., Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50(4):298-301.
5. Gudjonsson J.E., Ding J., Johnston A., Tejasvi T., Guzman A.M., Nair R.P., et al. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 2010, 130(7):1829-1840.
6. LaDuca J.R., Gaspari A.A. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases. Dermatol Clin 2001, 19(4):617-635.
7. Prens E.P., van Joost T., Hegmans J.P., t Hooft-Benne K., Ysselmuiden O.E., Benner R. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol 1995, 33(6):947-953.
8. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19(1):92-105.
9. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33(4):1290-1297.
10. Gebeshuber C.A., Zatloukal K., Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009, 10(4):400-405.